Results 11 to 20 of about 34,235 (247)

A Metabolism Perspective on Pediatric Rhabdomyolysis

Trends in Pediatrics, 2021
Rhabdomyolysis is a clinical emergency that can result in life-threatening complications. The etiology for rhabdomyolysis is broad. Infecitons are the most common cause in pediatric patients.
Havva Yazıcı, Sema Kalkan Uçar
doaj   +2 more sources

Rhabdomyolysis due to Lamivudine administration in acute viral hepatitis B infection: a case report from Malaysia

Electronic Physician, 2014
Rhabdomyolysis is a serious but rare side effect of Lamivudine treatment. Therefore, appropriate biochemical monitoring should be undertaken when it is used in the treatment of hepatitis B.
Janudin Baharin, Narisa Sulaiman Sahari, Sazlyna Mohd Sazlly Lim   +2 more
doaj   +2 more sources

Pediatric COVID-19 Associated Rhabdomyolysis [PDF]

, 2021
The incidence of rhabdomyolysis secondary to various causes has been reported, especially for viral infections such as influenzas. It is well established that Coronavirus disease-2019 (COVID-19) can include a large array of symptoms during the disease ...
Parisa Armanpoor, Parvaneh Armanpoor
core   +1 more source

The management and diagnosis of rhabdomyolysis induced acute kidney injury: a case study [PDF]

, 2022
Rhabdomyolysis is characterised by a rapid dissolution of damaged or injured skeletal muscle which can be caused by a multitude of different mechanisms. It can range in severity from mild to severe leading to multi organ failure and death. Rhabdomyolysis
Mortimore, G., Torr, L.
core   +1 more source

Rhabdomyolysis Associated With Heated Massage Therapy in a Patient Without Major Trauma: A Case Report. [PDF]

Clin Case Rep
ABSTRACT A 29‐year‐old professional dancer developed rhabdomyolysis after distal radial fracture fixation complicated by laryngospasm, negative pressure pulmonary oedema, suxamethonium use, and ICU admission. Creatine phosphokinase (CPK) peaked at 36,429 U/L with dark urine and hyperkalaemia.
Ratnayake A, Warnakula S, Handapangoda Y, Rathnayake U, Athapaththu L, Rupasinghe S.   +5 more
europepmc   +2 more sources

Severe Hypokalemia With Rhabdomyolysis-A Case Report. [PDF]

Clin Case Rep
ABSTRACT Magnesium administration should be considered in severe or refractory hypokalemia with even normal serum magnesium; however, more research is needed to establish the evidence and take into account confounding factors. Severe hypokalemia can manifest with rhabdomyolysis, which can affect kidney function.
Shahzad T, Murray A.
europepmc   +2 more sources

Phenytoin-induced rhabdomyolysis [PDF]

, 2021
Rhabdomyolysis is a potentially life-threatening syndrome that can develop from a variety of causes. The most common causes are muscle injury, alcohol abuse, drugs, toxins and increased muscular activity.
Guler, Selda K., Guneş, Nalan, Çokal, Burcu G.   +2 more
core   +1 more source

Exploring the association between selective serotonin reuptake inhibitors and rhabdomyolysis risk based on the FDA pharmacovigilance database

Scientific Reports, 2023
Rhabdomyolysis is a syndrome potentially fatal and has been associated with selective serotonin reuptake inhibitors (SSRIs) treatment in a few case reports.
Yan Wang, Yajing Lin, Qing Lin, Haiming Liang, Weiming Cai, Dongbo Jiang   +5 more
doaj   +1 more source

Phenotype standardization for statin-induced myotoxicity. [PDF]

, 2014
Statins are widely used lipid-lowering drugs that are effective in reducing cardiovascular disease risk. Although they are generally well tolerated, they can cause muscle toxicity, which can lead to severe rhabdomyolysis.
Fahy, J., Neely, D, Fahy, J, Wadelius, M, Palmer, CN, Carr, D. F., Maitland-van Der Zee, AH, Laaksonen, R, Maitland-van Der Zee, A. H., Wadelius, M., Yue, QY, Chinoy, H.; id_orcid, Psaty, BM, Bloch, K. M., Cooper, R. G., Neely, D., Psaty, B. M., Chinoy, H., Pirmohamed, M., Chinoy, H, Palmer, C. N. A., Voora, D, Palmer, C. N. A.; id_orcid, Voora, D., Armitage, J., Wadelius, Mia,, Yue, Q. Y., Alfirevic, A., Alfirevic, A, Armitage, J, Palmer, C. N A, Pirmohamed, M, Palmer, PN, Hanson, A., Bloch, KM, Laaksonen, R., Cooper, RG, Yue, Q-Y, Wadelius, Mia, Carr, DF, Hanson, A   +40 more
core   +1 more source

Association between proton pump inhibitors and rhabdomyolysis risk: a post-marketing surveillance using FDA adverse event reporting system (FAERS) database

Therapeutic Advances in Drug Safety, 2023
Background: This research aims to explore and compare the signals of rhabdomyolysis from the use of Proton pump inhibitors (PPIs) using the United States Food and Drug Administration Adverse Event Reporting System (FAERS) database.
Ali F. Altebainawi, Lulwa A. Alfaraj, Amjad A. Alharbi, Fadwa F. Alkhuraisi, Thamir M. Alshammari   +4 more
doaj   +1 more source